X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (279) 279
male (160) 160
female (149) 149
index medicus (149) 149
middle aged (85) 85
adult (83) 83
transient myeloproliferative disorder (66) 66
hematology (65) 65
aged (56) 56
thrombocytopenia (52) 52
risk factors (51) 51
transient elastography (49) 49
down syndrome (47) 47
pediatrics (47) 47
infant, newborn (44) 44
stroke (44) 44
diagnosis (38) 38
oncology (38) 38
infant (36) 36
child (35) 35
animals (34) 34
down syndrome - complications (33) 33
clinical neurology (32) 32
research (32) 32
acute megakaryoblastic leukemia (31) 31
child, preschool (31) 31
children (30) 30
ischemic attack, transient - etiology (30) 30
mutation (30) 30
gastroenterology & hepatology (29) 29
transient ischemic attack (29) 29
fibrosis (28) 28
treatment outcome (28) 28
health aspects (27) 27
leukemia (27) 27
peripheral vascular disease (27) 27
platelet count (27) 27
adolescent (26) 26
disease (26) 26
patients (26) 26
retrospective studies (26) 26
liver (25) 25
cirrhosis (24) 24
down-syndrome (24) 24
thrombosis (23) 23
biopsy (22) 22
care and treatment (22) 22
liver fibrosis (22) 22
time factors (22) 22
hepatitis (21) 21
medicine (21) 21
research article (21) 21
therapy (21) 21
prospective studies (20) 20
x-linked thrombocytopenia (20) 20
liver diseases (19) 19
medicine, general & internal (19) 19
prognosis (19) 19
acute myeloid-leukemia (18) 18
aspirin (18) 18
liver cirrhosis (18) 18
pathology (18) 18
stroke - etiology (18) 18
analysis (17) 17
gata1 transcription factor - genetics (17) 17
infection (17) 17
infections (17) 17
management (17) 17
platelet aggregation inhibitors - therapeutic use (17) 17
surgery (17) 17
antibodies (16) 16
liver cirrhosis - pathology (16) 16
mortality (16) 16
pregnancy (16) 16
thrombocytopenia - etiology (16) 16
abridged index medicus (15) 15
diagnosis, differential (15) 15
follow-up studies (15) 15
hepatitis c (15) 15
infants (15) 15
infectious diseases (15) 15
ischemic attack, transient - drug therapy (15) 15
platelets (15) 15
recurrence (15) 15
risk (15) 15
viruses (15) 15
anemia (14) 14
blood platelets (14) 14
cancer (14) 14
complications and side effects (14) 14
down syndrome - genetics (14) 14
gata1 (14) 14
hematopoiesis (14) 14
liver - pathology (14) 14
medical research (14) 14
megakaryoblastic leukemia (14) 14
multidisciplinary sciences (14) 14
acquired mutations (13) 13
blood (13) 13
chronic hepatitis-c (13) 13
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (360) 360
German (8) 8
French (3) 3
Russian (3) 3
Japanese (2) 2
Korean (1) 1
Polish (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of Thrombosis and Haemostasis, ISSN 1538-7933, 05/2012, Volume 10, Issue 5, pp. 799 - 806
Background:  Eltrombopag is an oral, non‐peptide thrombopoietin receptor agonist that has shown efficacy and safety in chronic immune thrombocytopenia (ITP).... 
pharmacokinetics | bleeding | eltrombopag | immune thrombocytopenia | Eltrombopag | Immune thrombocytopenia | Pharmacokinetics | Bleeding | MANAGEMENT | PLATELET COUNTS | ITP | HEALTHY-SUBJECTS | PURPURA | ADULTS | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | Benzoates - adverse effects | Japan - epidemiology | Blood Platelets - immunology | Hemorrhage - ethnology | Humans | Middle Aged | Hematologic Agents - pharmacokinetics | Male | Hemorrhage - prevention & control | Purpura, Thrombocytopenic, Idiopathic - blood | Purpura, Thrombocytopenic, Idiopathic - drug therapy | Time Factors | Purpura, Thrombocytopenic, Idiopathic - immunology | Placebos | Adult | Female | Blood Platelets - drug effects | Pyrazoles - pharmacokinetics | Hydrazines - administration & dosage | Pyrazoles - adverse effects | Hematologic Agents - adverse effects | Double-Blind Method | Administration, Oral | Hemorrhage - immunology | Hydrazines - pharmacokinetics | Treatment Outcome | Hemorrhage - blood | Purpura, Thrombocytopenic, Idiopathic - ethnology | Benzoates - administration & dosage | Receptors, Thrombopoietin - agonists | Asian Continental Ancestry Group | Pyrazoles - administration & dosage | Platelet Count | Blood Platelets - metabolism | Aged | Hematologic Agents - administration & dosage | Receptors, Thrombopoietin - blood | Chronic Disease | Benzoates - pharmacokinetics | Hydrazines - adverse effects | Thrombocytopenia | thrombopoietin receptors | Transient ischemic attack | Platelets | Thrombosis
Journal Article
The Indian Journal of Pediatrics, ISSN 0019-5456, 3/2014, Volume 81, Issue 3, pp. 266 - 269
Journal Article
European Journal of Haematology, ISSN 0902-4441, 11/2014, Volume 93, Issue 5, pp. 439 - 445
Objectives Thrombocytopenia is an independent adverse prognostic factor in patients with Myelodysplastic syndromes (MDS). Azacitidine, first‐line treatment for... 
thrombocytopenia | eltrombopag | Myelodysplastic syndrome | azacitidine | thrombopoietin‐receptor | Thrombocytopenia | Thrombopoietin-receptor | Eltrombopag | Azacitidine | LEUKEMIA GROUP-B | SURVIVAL | STEM-CELLS | IMPACT | thrombopoietin-receptor | PROLIFERATION | HEMATOLOGY | CANCER | Blood Platelets - pathology | Benzoates - adverse effects | Azacitidine - adverse effects | Humans | Middle Aged | Male | Antineoplastic Agents - administration & dosage | Thrombocytopenia - complications | Thrombocytopenia - drug therapy | Antineoplastic Agents - adverse effects | Ischemic Attack, Transient - etiology | Aged, 80 and over | Female | Blood Platelets - drug effects | Drug Therapy, Combination | Hydrazines - administration & dosage | Myelodysplastic Syndromes - drug therapy | Azacitidine - administration & dosage | Ischemic Attack, Transient - pathology | Pyrazoles - adverse effects | Hematopoietic Stem Cells - drug effects | Myelodysplastic Syndromes - metabolism | Treatment Outcome | Thrombocytopenia - pathology | Myelodysplastic Syndromes - complications | Receptors, Thrombopoietin - metabolism | Remission Induction | Thrombocytopenia - metabolism | Venous Thrombosis - etiology | Benzoates - administration & dosage | Drug Synergism | Receptors, Thrombopoietin - agonists | Pilot Projects | Pyrazoles - administration & dosage | Platelet Count | Aged | Venous Thrombosis - pathology | Cell Cycle - drug effects | Myelodysplastic Syndromes - pathology | Hydrazines - adverse effects | Antimitotic agents | Medical research | Complications and side effects | Care and treatment | Safety and security measures | Leukemia | Clinical trials | Medicine, Experimental | Antineoplastic agents | Clinical Medicine | Medical and Health Sciences | Medicin och hälsovetenskap | Cancer and Oncology | Klinisk medicin | Cancer och onkologi
Journal Article
Emergency Medicine Clinics of North America, ISSN 0733-8627, 2009, Volume 27, Issue 3, pp. 505 - 523
Journal Article
Journal of Gastroenterology, ISSN 0944-1174, 8/2010, Volume 45, Issue 8, pp. 876 - 884
Journal Article
American Journal of Medical Genetics Part A, ISSN 1552-4825, 04/2017, Volume 173, Issue 4, pp. 897 - 904
Journal Article